86 related articles for article (PubMed ID: 1796983)
1. Changes in body composition and energy expenditure after six weeks' growth hormone treatment.
Pfadt A; Angulo M
Arch Dis Child; 1991 Oct; 66(10):1261. PubMed ID: 1796983
[No Abstract] [Full Text] [Related]
2. Body composition studies in Prader-Willi syndrome: effects of growth hormone therapy.
Lee PD; Hwu K; Henson H; Brown BT; Bricker JT; LeBlanc AD; Fiorotto ML; Greenberg F; Klish WJ
Basic Life Sci; 1993; 60():201-5. PubMed ID: 8110110
[No Abstract] [Full Text] [Related]
3. Prader-Willi syndrome: how does growth hormone affect body composition and physical function?
Carrel AL; Allen DB
J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1445-51. PubMed ID: 11837498
[TBL] [Abstract][Full Text] [Related]
4. Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome.
Haqq AM; Stadler DD; Jackson RH; Rosenfeld RG; Purnell JQ; LaFranchi SH
J Clin Endocrinol Metab; 2003 May; 88(5):2206-12. PubMed ID: 12727976
[TBL] [Abstract][Full Text] [Related]
5. Dietary Energy Intake, Body Composition and Resting Energy Expenditure in Prepubertal Children with Prader-Willi Syndrome before and during Growth Hormone Treatment: A Randomized Controlled Trial.
Bakker NE; Siemensma EP; Koopman C; Hokken-Koelega AC
Horm Res Paediatr; 2015; 83(5):321-31. PubMed ID: 25764996
[TBL] [Abstract][Full Text] [Related]
6. Changes in body composition and energy expenditure after six weeks' growth hormone treatment.
Gregory JW; Greene SA; Jung RT; Scrimgeour CM; Rennie MJ
Arch Dis Child; 1991 May; 66(5):598-602. PubMed ID: 2039249
[TBL] [Abstract][Full Text] [Related]
7. Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study.
Carrel AL; Myers SE; Whitman BY; Allen DB
J Clin Endocrinol Metab; 2002 Apr; 87(4):1581-5. PubMed ID: 11932286
[TBL] [Abstract][Full Text] [Related]
8. Five-years growth hormone (GH) treatment in adults with Prader-Willi syndrome.
Höybye C
Acta Paediatr; 2007 Mar; 96(3):410-3. PubMed ID: 17407467
[TBL] [Abstract][Full Text] [Related]
9. Carbohydrate metabolism is not impaired after 3 years of growth hormone therapy in children with Prader-Willi syndrome.
L'Allemand D; Eiholzer U; Schlumpf M; Torresani T; Girard J
Horm Res; 2003; 59(5):239-48. PubMed ID: 12714788
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone therapy in the Prader-Willi syndrome.
Paterson WF; Donaldson MD
Arch Dis Child; 2003 Apr; 88(4):283-5. PubMed ID: 12651746
[No Abstract] [Full Text] [Related]
11. Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome.
Carrel AL; Moerchen V; Myers SE; Bekx MT; Whitman BY; Allen DB
J Pediatr; 2004 Dec; 145(6):744-9. PubMed ID: 15580194
[TBL] [Abstract][Full Text] [Related]
12. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
Myers SE; Carrel AL; Whitman BY; Allen DB
J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
[TBL] [Abstract][Full Text] [Related]
13. Effect of growth hormone on height, weight, and body composition in Prader-Willi syndrome.
Davies PS; Evans S; Broomhead S; Clough H; Day JM; Laidlaw A; Barnes ND
Arch Dis Child; 1998 May; 78(5):474-6. PubMed ID: 9659098
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of growth hormone therapy on patients with Prader-Willi syndrome.
Sipilä I; Sintonen H; Hietanen H; Apajasalo M; Alanne S; Viita AM; Leinonen E
Acta Paediatr; 2010 Nov; 99(11):1712-8. PubMed ID: 20545932
[TBL] [Abstract][Full Text] [Related]
15. Effects of growth hormone in Prader-Willi syndrome.
Connor EL; Rosenbloom A
Clin Pediatr (Phila); 1993 May; 32(5):296-7. PubMed ID: 8324973
[No Abstract] [Full Text] [Related]
16. Is scoliosis an issue for giving growth hormone to children with Prader-Willi syndrome?
Diene G; de Gauzy JS; Tauber M
Arch Dis Child; 2008 Dec; 93(12):1004-6. PubMed ID: 19028967
[No Abstract] [Full Text] [Related]
17. Growth hormone treatment of patients with Prader-Willi syndrome. Swedish Growth Hormone Advisory Group.
Ritzén EM; Lindgren AC; Hagenäs L; Marcus C; Müller J; Blichfeldt S
J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():345-9. PubMed ID: 10698600
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone treatment downregulates serum leptin levels in children independent of changes in body mass index.
Elimam A; Lindgren AC; Norgren S; Kamel A; Skwirut C; Bang P; Marcus C
Horm Res; 1999; 52(2):66-72. PubMed ID: 10681635
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of long-term Norditropin® treatment in children with Prader-Willi syndrome.
Meinhardt U; Christiansen JS; Farholt S; Lämmer C; Ostergaard JR; Schmidt F; Kappelgaard AM; Eiholzer U
Horm Metab Res; 2013 Jul; 45(7):532-6. PubMed ID: 23632904
[TBL] [Abstract][Full Text] [Related]
20. Effects of growth hormone in Prader-Willi syndrome. A case report.
Ruvalcaba RH; Holm VA
Clin Pediatr (Phila); 1993 May; 32(5):292-5. PubMed ID: 8324972
[No Abstract] [Full Text] [Related]
[Next] [New Search]
